Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 18/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3587238 | 0.78 | MAPK14 (0.49) | MCHR1MAPK14KCNH2 | |
| SCHEMBL3602692 | 0.77 | MCHR1 (0.42) | MCHR1MAPK14KCNH2 | |
| SCHEMBL13080920 | 0.72 | MCHR1 (0.40) | MCHR1MAPK14KCNH2 | |
| SCHEMBL4585147 | 0.72 | — | — | |
| SCHEMBL4585961 | 0.71 | CALCRL (0.47) | — | |
| SCHEMBL3587241 | 0.71 | MAPK14 (0.47) | MCHR1MAPK14KCNH2 | |
| SCHEMBL7641512 | 0.68 | MAPK14 (0.62) | MCHR1MAPK14 | |
| SCHEMBL6134673 | 0.66 | MAPK14 (0.41) | MCHR1MAPK14KCNH2 | |
| SCHEMBL4488171 | 0.66 | HTR6 (0.50) | MCHR1MAPK14 | |
| SCHEMBL1365787 | 0.65 | MCHR1 (0.71) | MCHR1MAPK14KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1689493-A4 | CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS | BRISTOL MYERS SQUIBB CO (US) | 2008-04-23 | — | — | EP | disclosed |
| EP-1689493-A1 | CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS | Bristol-Myers Squibb Pharma Company (US) | 2006-08-16 | — | — | EP | disclosed |
| WO-2005065779-A1 | CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-07-21 | — | — | WO | disclosed |